Medically Reviewed

What Are the Types of Non-Hodgkin Lymphoma?

Each cancer has a subtype that differs based on where it starts, how slowly or quickly it spreads, and how it affects the patient. Non-Hodgkin lymphoma (NHL) is the most common type of lymphoma and has more than 70 subtypes.

Here’s a look at the primary types and subtypes of NHL.


What Is Non-Hodgkin Lymphoma?

NHL is not a single cancer but a group of blood cancers developing in the lymphatic system. “Non-Hodgkin lymphomas are malignant transformations of your B cells, T cells, and NK (natural killer) cells,” said Danielle Leonardo, MD, an oncologist and writer at My BC Team.

There are more than 70 types of NHL, which are categorized by their aggressiveness or lack thereof.


Non-Hodgkin vs. Hodgkin Lymphoma

Although both are types of lymphoma, non-Hodgkin and Hodgkin lymphoma affect a patient’s body differently.

“Two major classifications of lymphomas are your Hodgkin and non-Hodgkin lymphoma, which are differentiated under a microscope,” Dr. Leonardo said. “The presence of Reed-Sternberg cells classifies the lymphoma as Hodgkin, and its absence makes it non-Hodgkin lymphoma.”


Indolent Lymphomas

Indolent lymphoma is an NHL that grows slowly in the body and tends to have fewer signs and symptoms. About 40% of patients are diagnosed with this type of NHL. Follicular lymphoma is the most common indolent non-Hodgkin lymphoma and starts in the B lymphocytes.

Other types of indolent NHL include the following:


Aggressive Lymphomas

Aggressive lymphomas are NHL that grow and spread quickly in the body and account for about 60% of NHL cases.

There are more than 10 types of aggressive lymphoma, some of which include the following:


Types of NHL by Cell of Origin

NHL can be further divided into subtypes based on their cell of origin, which includes precursor B and T cells and mature B and T cells, Dr. Leonardo said.

Below are examples of each subtype of precursor and mature B and T cell NHL:

  • Precursor B and T cells
    • Lymphoblastic lymphoma
  • Mature B cells
    • Diffuse large B-cell lymphoma
    • Burkitt lymphoma
    • Mantle cell lymphoma
  • Mature T cells
    • Anaplastic large-cell lymphoma
    • Peripheral T-cell lymphoma
    • Cutaneous T-cell lymphoma

Most Common NHL Subtypes

Within the many subtypes of NHL, some are more commonly diagnosed than others.

“The most common subtypes of NHL are diffuse large B-cell lymphoma, which account for 30% of all NHL cases, followed by follicular lymphoma, accounting for 20%,” Dr. Leonardo said. “MALT lymphoma, peripheral T-cell lymphoma, small-cell lymphocytic lymphoma and mantle cell lymphoma each account for 6% to 7% of NHL cases.”


Indolent and Aggressive Lymphoma Symptoms

Patients with NHL can experience various symptoms that often resemble other health conditions. With this in mind, patients must seek medical care for an official diagnosis.

Common symptoms of NHL include:

  • Swollen lymph nodes
  • Abdominal pain or swelling
  • Chest pain
  • Coughing
  • Persistent tiredness
  • Unexplained fever
  • Intense night sweats
  • Unexplained weight loss
  • A feeling of fullness in the stomach

NHL Risk Factors

Although there’s no exact cause for each of the various subtypes of NHL, certain risk factors make individuals susceptible to developing this cancer.

Risk factors for NHL may include:

  • Age
  • Sex
  • Race and ethnicity
  • Geography
  • Family history
  • Exposure to radiation, certain chemicals, and drugs
  • Certain autoimmune conditions
  • Having a weakened immune system
  • Certain infections
  • Being overweight or obese
  • Breast implants

Treating and Managing Indolent and Aggressive NHL

Due to how rapidly aggressive NHL subtypes are, treatment starts immediately after diagnosis. Typically, patients with aggressive NHL are initially treated with chemotherapy.

However, treatment ultimately depends on the type of cancer, how advanced it is, and the patient’s current state of health.


This article was originally published December 4, 2023 and most recently updated December 8, 2023.